STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $388,000 | +52.8% | 190,057 | +122.3% | 0.00% | – |
| Q2 2021 | $254,000 | +1.6% | 85,489 | -5.5% | 0.00% | – |
| Q1 2021 | $250,000 | +190.7% | 90,476 | +153.1% | 0.00% | – |
| Q4 2020 | $86,000 | +207.1% | 35,750 | +167.0% | 0.00% | – |
| Q3 2020 | $28,000 | -28.2% | 13,391 | +30.0% | 0.00% | – |
| Q2 2020 | $39,000 | +105.3% | 10,300 | +0.8% | 0.00% | – |
| Q1 2020 | $19,000 | -40.6% | 10,223 | -33.3% | 0.00% | – |
| Q4 2019 | $32,000 | -27.3% | 15,318 | -16.0% | 0.00% | – |
| Q3 2019 | $44,000 | -94.3% | 18,239 | -92.6% | 0.00% | – |
| Q2 2019 | $778,000 | +56.2% | 248,141 | +199.2% | 0.00% | – |
| Q2 2018 | $498,000 | – | 82,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 978,907 | $6,865,000 | 3.28% |
| RA Capital Management | 2,690,702 | $20,449,000 | 2.02% |
| NEA Management Company, LLC | 2,141,308 | $16,274,000 | 1.04% |
| Broadfin Capital, LLC | 1,656,705 | $10,911,000 | 0.67% |
| Tredje AP-fonden | 909,581 | $6,913,000 | 0.44% |
| Granite Point Capital Management, L.P. | 388,945 | $2,679,000 | 0.40% |
| Ghost Tree Capital, LLC | 72,726 | $553,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 181,818 | $1,382,000 | 0.20% |
| Tower Research Capital LLC (TRC) | 1,094 | $8,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,114 | $24,000 | 0.00% |